Efficacy and safety of BH4 before the age of 4 years in patients with mild phenylketonuria
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of BH4 before the age of 4 years in patients with mild phenylketonuria
Authors
Keywords
-
Journal
JOURNAL OF INHERITED METABOLIC DISEASE
Volume 35, Issue 6, Pages 975-981
Publisher
Springer Nature
Online
2012-03-04
DOI
10.1007/s10545-012-9464-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlation of age-specific phenylalanine levels with intellectual outcome in patients with phenylketonuria
- (2011) Krista S. Viau et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Bone metabolism and the muscle–bone relationship in children, adolescents and young adults with phenylketonuria
- (2010) Piotr Adamczyk et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism
- (2010) Ania C. Muntau et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Tetrahydrobiopterin Therapy for Phenylketonuria in Infants and Young Children
- (2010) Barbara K. Burton et al. JOURNAL OF PEDIATRICS
- Suboptimal outcomes in patients with PKU treated early with diet alone: Revisiting the evidence
- (2010) G.M. Enns et al. MOLECULAR GENETICS AND METABOLISM
- Sapropterin therapy increases stability of blood phenylalanine levels in patients with BH4-responsive phenylketonuria (PKU)
- (2010) Barbara K. Burton et al. MOLECULAR GENETICS AND METABOLISM
- Challenges and Pitfalls in the Management of Phenylketonuria
- (2010) F. Feillet et al. PEDIATRICS
- Bone Impairment in Phenylketonuria Is Characterized by Circulating Osteoclast Precursors and Activated T Cell Increase
- (2010) Ilaria Roato et al. PLoS One
- Efficacy of Sapropterin Dihydrochloride in Increasing Phenylalanine Tolerance in Children with Phenylketonuria: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- (2009) Friedrich K. Trefz et al. JOURNAL OF PEDIATRICS
- Genotype-predicted tetrahydrobiopterin (BH4)-responsiveness and molecular genetics in Croatian patients with phenylalanine hydroxylase (PAH) deficiency
- (2009) Iva Karačić et al. MOLECULAR GENETICS AND METABOLISM
- Optimizing the use of sapropterin (BH4) in the management of phenylketonuria
- (2009) Nenad Blau et al. MOLECULAR GENETICS AND METABOLISM
- The role of intelligence in phenylketonuria: A review of research and management☆
- (2009) V.L. Brumm et al. MOLECULAR GENETICS AND METABOLISM
- Executive function in early-treated phenylketonuria: Profile and underlying mechanisms☆☆☆
- (2009) Shawn E. Christ et al. MOLECULAR GENETICS AND METABOLISM
- ADHD, learning, and academic performance in phenylketonuria
- (2009) Kevin M. Antshel MOLECULAR GENETICS AND METABOLISM
- Psychiatric symptoms and disorders in phenylketonuria☆
- (2009) V.L. Brumm et al. MOLECULAR GENETICS AND METABOLISM
- Evaluation of neonatal BH4 loading test in neonates screened for hyperphenylalaninemia
- (2008) François Feillet et al. EARLY HUMAN DEVELOPMENT
- Stability of blood phenylalanine levels and IQ in children with phenylketonuria
- (2008) Vera Anastasoaie et al. MOLECULAR GENETICS AND METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search